LSE:RKT 26 November 2025 - 9 February 2026

Reckitt shares dropped 3.8% to 5,788 pence in early London trading Monday, ahead of a shareholder vote on a £1.6 billion capital return plan set for Jan. 27. The proposal includes a 235p special dividend and a 24-for-25 share consolidation, with the record date on Jan. 30 and payment due Feb. 20. The moves follow the sale of Reckitt’s Essential Home business.

Reckitt Benckiser shares fell 1.57% Friday to 6,018 pence, trimming year-to-date gains to 0.3%. Shareholders vote Tuesday on a £1.6 billion special dividend and a 24-for-25 share consolidation after the Essential Home sale. The record date is Jan. 30, with shares going ex-dividend Feb. 2 and payment due Feb. 20, pending approval. The company faces ongoing litigation over its Mead Johnson infant formula in the U.S.

Reckitt Benckiser closed at 5,978p on 24 December, near recent highs after touching 6,080p on 19 December. Santander initiated coverage with an “outperform” rating and a 7,030p target, implying 17.6% upside. Other broker actions in December included downgrades from Morningstar and Morgan Stanley. The stock saw lighter holiday trading and awaits the Essential Home divestment deadline.

Reckitt Benckiser on Wednesday disclosed a repurchase of 58,400 shares at an average 5,993.10p each, with shares to be held in treasury. The company also announced a new distribution partnership with DKSH in Malaysia to expand its consumer health and hygiene reach. On December 15, Reckitt cancelled 30 million treasury shares. Total voting rights now stand at 672,455,622 shares.

Reckitt Benckiser confirmed a buyback of 49,820 shares on 12 December 2025 at an average price of 6,020.91p. Shares traded at 5,972p on 15 December, down 0.47%. The company’s £1 billion buyback programme is in its second tranche, set to run until 30 January 2026. Reckitt now holds 59.5 million shares in treasury.

Reckitt shares closed Friday at 6,000p, up 1.66% for the week, after steady buybacks and renewed focus on Emerging Markets. The company repurchased over 116,000 shares this week under its £250 million buyback plan. No earnings are scheduled, with attention shifting to UK inflation data and the Bank of England decision next week.